All content for Byolete is the property of Byolete and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to The Chemist Couple podcast! With GLP-1 medications like Mounjaro becoming more popular, are we overlooking the risks? From potential nutrient deficiencies to serious health concerns like pancreatitis and diabetic retinopathy, we break it all down. Don't let the hype overshadow the science! ⚠️
⏱️ Timestamps:
00:00 - The Rise of GLP-1s: Why Are They So Popular?
01:56 - Eating Less = Harm? The Hidden Risks
03:43 - Losing Lean Mass: What You Need to Know
04:55 - The Risk of Vitamin Deficiencies
05:58 - Can You Keep the Weight Off? Leptin Explained
07:51 - Lifestyle Changes: Key to Long-Term Success
10:18 - The ‘Golden Dose’: A Dangerous Shortcut?
11:57 - ‘Microdosing’ GLP-1s: Risky & Unlicensed!
14:31 - Surgery & Aspiration: A New GLP-1 Warning
18:36 - Just How Powerful Are GLP-1s?
19:32 - Diabetic Retinopathy: An Overlooked Side Effect
22:05 - Pancreatitis: A Rare but Serious Risk
23:55 - Fertility, Pregnancy & Breastfeeding: What’s Safe?
29:20 - Planning a Pregnancy? Here’s What to Consider
30:21 - Final Thoughts: Are GLP-1s Worth the Risk?
🔔 Subscribe to The Chemist Couple Podcast:
Stay on top of the latest science-based preventative health tips. Hit the like button and tell us: What are your thoughts on GLP-1 medication?
🎙️ Listen to our podcast:
Spotify 🎧: The Chemist Couple PodcastApple Podcasts 🍏: The Chemist Couple Podcast
📩 Sign up for our newsletter to learn how we personally apply science to enhance our lifestyle: Join Here
📺 Watch this episode on YouTube: The Chemist Couple Podcast
📚 Studies Referenced in This Episode:
Guyton & Hall Medical Physiology (14th Edition) – General physiology overview
Rang & Dale’s Pharmacology (10th Edition) – General pharmacological overview
Electronic Medicines Compendium (EMC): Mounjaro (tirzepatide) Summary of Product Characteristics – Read Here
Diabetes & Primary Care, Vol 23 No 4 (2021): GLP-1 receptor agonists and diabetic retinopathy – Read Here
⚠️ Disclaimer: This podcast is for informational purposes only and should not replace advice from a healthcare professional. If you have any questions, reach out to us. Thanks for watching!
